인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
DBpia AI
AI 에이전트
AI 아이디어
AI 리더
AI 뷰어
Citeasy
크롬 서지관리 다운로드
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록·키워드
Abstract Background and aims Although current guidelines recommend endoscopic papillectomy (EP) as the first-line intervention for noninvasive ampullary tumors, there is no consensus on its use for tumors of the minor duodenal papilla (Midp). Therefore, this study aims to evaluate the efficacy and safety of EP for Midp tumors based on our experience and a review of the literature. Methods The study involved two steps: first, a retrospective, single-center analysis of Midp tumors treated at our hospital, and second, a literature review to assess the procedures and outcomes of EP for Midp tumors. Results EP was successfully performed in five patients with Midp tumors at our hospital, with no adverse events reported. Complete resection (R0 resection) was achieved in three cases, and all five patients remained recurrence-free during follow-up. Among 93 cases from 31 articles included in the literature review, 86.57% (58/67) of patients achieved complete resection (R0 resection). Residual lesions were observed in 7.94% (5/63) of patients, but additional treatments such as argon plasma coagulation or repeat EP achieved favorable outcomes. No severe complications were reported, and all patients recovered with conservative management. Adenoma recurrence was observed in 3.23% (3/93) of patients during follow-up. Two of these patients underwent repeat endoscopic treatment and recovered successfully. Conclusions This study demonstrates that EP is a safe and effective treatment for tumors of the minor duodenal papilla. The short-term and long-term outcomes of EP are acceptable, and repeat endoscopic treatment is feasible for achieving clinical cure in cases of tumor recurrence.
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
최근 본 자료 전체보기
